The first study of the cost-effectiveness of typhoid conjugate vaccines found that routinely immunizing infants at 9 months of age would actually save costs in 2 settings (Delhi, India and a rural area of Vietnam), due to high incidence or high hospitalization rates, and would be cost-effective in the study’s 3 other sites (in India and Kenya). Adding a one-time catch-up campaign for various older age groups would still save costs in Delhi and Vietnam, and increase the cost-effectiveness in the others, making it economically justifiable.
Full Citation:
Antillon M, Bilcke J, Paltiel AD, Pitzer VE. 2017. Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings. Vaccine. 35.
Title of Article: Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings
Author(s): Antillon M, Bilcke J, Paltiel AD, Pitzer VE
Publication Year: 2017
Publication Name: Vaccine
Publication Volume: 35
Publication Source URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462484/pdf/main.pdf
DOI (Digital Object Identifier): http://dx.doi.org/10.1016/j.vaccine.2017.05.001
Topics: Economics & Return on Investment
Disease Vaccines: Typhoid
WHO Regions: South-East Asia | Western Pacific